Keep pulling the thread on Andrew Dudum.
Erectile dysfunction is the only physical symptom of cardiovascular disease.
Hims & Hers' revenue guidance for the current year is approximately $3 billion.
Hims & Hers was able to manufacture and sell compounded GLP-1 drugs for approximately $150, compared to the $1,500 price of the FDA-approved brand-name medication.
Brand-name GLP-1 medications are now available to consumers for $150.
Andrew Dudum predicts that GLP-1s will have a greater impact on global society over the next 5 years than AI.
Semaglutide is expected to go generic in the US in approximately four years.
The era of unrestrained profit margins for pharmaceutical companies is over.
Eli Lilly is developing a new medication in early-phase trials that could eliminate cardiovascular risk with a single annual injection.
Andrew Dudum predicts that gene editing technologies will be able to fix root medical issues, rather than just treating symptoms, within the next five years.
Nearly half of Americans are unable to access or afford quality healthcare.
Long wait times for medical appointments cause nearly 40% of Americans to delay or skip care.
Hims & Hers has more than 2.5 million subscribers.